Clinical Trial Update: Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Caelyx (liposomal doxorubicin) plus carboplatin with paclitaxel plus carboplatin in late-relapsed epithelial ovarian cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Caelyx (liposomal doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED